Matinas Biopharma (6LJ0.F) Q3 2024 Earnings

14AugConfirmed
Q3 2024
-1.14
-1.06
-0.98
-0.91

Details

Expected EPS
-1.135
Actual EPS
-0.908
Surprise EPS
0.23
Surprise Percent
+20%

Description

Matinas Biopharma (6LJ0.F) has reported earnings of -0.908 per share for Q3 2024.

0 Comments

Share your thoughts